"POEMS Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A multisystemic disorder characterized by a sensorimotor polyneuropathy (POLYNEUROPATHIES), organomegaly, endocrinopathy, monoclonal gammopathy, and pigmentary skin changes. Other clinical features which may be present include EDEMA; CACHEXIA; microangiopathic glomerulopathy; pulmonary hypertension (HYPERTENSION, PULMONARY); cutaneous necrosis; THROMBOCYTOSIS; and POLYCYTHEMIA. This disorder is frequently associated with osteosclerotic myeloma. (From Adams et al., Principles of Neurology, 6th ed, p1335; Rev Med Interne 1997;18(7):553-62)
| Descriptor ID |
D016878
|
| MeSH Number(s) |
C10.668.829.800.700 C15.378.147.780.750 C16.131.077.703 C20.683.780.750
|
| Concept/Terms |
POEMS Syndrome- POEMS Syndrome
- Syndrome, POEMS
- Takatsuki's Syndrome
- Syndrome, Takatsuki's
- Takatsuki Syndrome
- Polyneuropathy Organomegaly
- Organomegalies, Polyneuropathy
- Organomegaly, Polyneuropathy
- Polyneuropathy Organomegalies
- Crow-Fukase Syndrome
- Crow Fukase Syndrome
- Syndrome, Crow-Fukase
- Polyneuropathy, Organomegaly, Endocrinopathy, M Protein, and Skin Changes Syndrome
|
Below are MeSH descriptors whose meaning is more general than "POEMS Syndrome".
Below are MeSH descriptors whose meaning is more specific than "POEMS Syndrome".
This graph shows the total number of publications written about "POEMS Syndrome" by people in this website by year, and whether "POEMS Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 2 | 1 | 3 |
| 2018 | 3 | 0 | 3 |
| 2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "POEMS Syndrome" by people in Profiles.
-
Successful second outpatient autologous hematopoietic cell transplant for relapsed POEMS syndrome in a patient with coexisting HIV, HBV and syphilis infections during the COVID-19 pandemic. Transpl Immunol. 2021 08; 67:101412.
-
High-dose therapy and autologous transplantation for POEMS Syndrome: effective, but how to optimise? Br J Haematol. 2019 09; 186(6):e178-e181.
-
Prevalence and Course of Endocrinopathy in POEMS Syndrome. J Clin Endocrinol Metab. 2019 06 01; 104(6):2140-2146.
-
Advances in POEMS treatment and the need to define standardised outcome measures. Br J Haematol. 2019 04; 185(2):386-388.
-
POEMS syndrome. Curr Opin Neurol. 2018 10; 31(5):551-558.
-
A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome. Am J Hematol. 2018 06; 93(6):803-809.
-
Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial. Br J Haematol. 2017 12; 179(5):748-755.
-
Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 2018 Jan; 57(1):E8-E13.
-
[Sarcoidosis flare after autologous stem cell transplantation: An immune paradox?] Rev Med Interne. 2017 Sep; 38(9):619-622.